Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine vs Behavioral Therapy in Body Focused Repetitive Behaviors
NCT05796752Phase 3Active, not recruiting
- Sponsor
- University of Chicago
- Start
- Aug 2023
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of memantine in trichotillomania (TTM), Excoriation Disorder, sponsored by University of Chicago. Started Aug 2023; status: active, not recruiting.
02
Drugs
memantine
03
Conditions
trichotillomania (TTM)Excoriation Disorder
Beyond the preview
Go deeper on NCT05796752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05796752.